Zobrazeno 1 - 10
of 500
pro vyhledávání: '"Giuseppe Procopio"'
Autor:
Sara Elena Rebuzzi, Giuseppe Fornarini, Alessio Signori, Sebastiano Buti, Giuseppe Procopio, Ugo De Giorgi, Sandro Pignata, Emanuele Naglieri, Marco Maruzzo, Giuseppe Luigi Banna, Pasquale Rescigno, Carlo Messina, Alvise Mattana, Umberto Basso, Davide Bimbatti
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-5 (2024)
Abstract Background Nowadays, different therapeutic options are available for the first-line treatment of metastatic renal cell carcinoma (mRCC). Immuno-combinations are the standard first-line therapy in all mRCC patients regardless of the Internati
Externí odkaz:
https://doaj.org/article/07fb9d1891ed48f8877a4dc092e2bedf
Publikováno v:
Physics, Vol 6, Iss 2, Pp 801-827 (2024)
Starting from the analysis of the lack of positivity of the Cattaneo heat equation, this work addresses the thermodynamic relevance of the positivity constraint in irreversible thermodynamics, that is at least as significant as the entropic constrain
Externí odkaz:
https://doaj.org/article/bfa807bd6f9e4fa9b553c5881466f412
Autor:
Sara Demurtas, Mara Frascaroli, Federico Sottotetti, Alessandro Rametta, Giuseppe Procopio, Laura Deborah Locati
Publikováno v:
Journal of Kidney Cancer and VHL, Vol 11, Iss 2 (2024)
Clear cell renal carcinoma (ccRCC) can occur in young people and could be associated with an aggressive behavior. While for the first-line treatment in metastatic disease, there is an agreement to rely on an immunotherapy (IO)-based combination regim
Externí odkaz:
https://doaj.org/article/8554d7d7c1e64d0fae0af3e6e18f9cc5
Autor:
Veronica Murianni, Alessio Signori, Sebastiano Buti, Sara Elena Rebuzzi, Davide Bimbatti, Ugo De Giorgi, Silvia Chiellino, Luca Galli, Paolo Andrea Zucali, Cristina Masini, Emanuele Naglieri, Giuseppe Procopio, Michele Milella, Lucia Fratino, Cinzia Baldessari, Riccardo Ricotta, Veronica Mollica, Mariella Sorarù, Marianna Tudini, Veronica Prati, Andrea Malgeri, Francesco Atzori, Marilena Di Napoli, Orazio Caffo, Massimiliano Spada, Franco Morelli, Giuseppe Prati, Franco Nolè, Francesca Vignani, Alessia Cavo, Helga Lipari, Giandomenico Roviello, Fabio Catalano, Alessandra Damassi, Malvina Cremante, Pasquale Rescigno, Giuseppe Fornarini, Giuseppe Luigi Banna
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundImmunotherapies exhibit peculiar cancer response patterns in contrast to chemotherapy and targeted therapy. Some patients experience disease response after initial progression or durable responses after treatment interruption. In clinical p
Externí odkaz:
https://doaj.org/article/00c6e5c2760c42988d637261a6a49e07
Autor:
Giuseppe Procopio, Massimiliano Giona
Publikováno v:
Mathematics in Engineering, Vol 5, Iss 2, Pp 1-34 (2023)
This paper develops the bitensorial formulation of the system of singularities associated with unbounded and bounded Stokes flows. The motivation for this extension is that Stokesian singularities and hydrodynamic fundamental solutions are multi-poin
Externí odkaz:
https://doaj.org/article/ecc8e4e630f944d6a2ce659a3519354a
Autor:
Pierangela Sepe, Giuseppe Procopio, Chiara Carlotta Pircher, Umberto Basso, Orazio Caffo, Vera Cappelletti, Melanie Claps, Ugo De Giorgi, Lucia Fratino, Valentina Guadalupi, Patrizia Miodini, Cinzia De Marco, Bruno Perrucci, Alessia Mennitto, Daniele Santini, Francesco Spina, Marco Stellato, Filippo de Braud, Elena Verzoni
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 16 (2024)
Background: Up to 30% of patients with metastatic castration-resistant prostate cancer (mCRPC) develop visceral metastases, which are associated with a poor prognosis. Objectives: Efficacy of enzalutamide in mCRPC patients with measurable metastases,
Externí odkaz:
https://doaj.org/article/21ea7ba220ad4b319c9536d754e3134f
Autor:
Pier Vitale Nuzzo, Filippo Pederzoli, Calogero Saieva, Elisa Zanardi, Giuseppe Fotia, Andrea Malgeri, Sabrina Rossetti, Loana Valenca Bueno, Livia Maria Q. S. Andrade, Anna Patrikidou, Ricardo Pereira Mestre, Mikol Modesti, Sandro Pignata, Giuseppe Procopio, Giuseppe Fornarini, Ugo De Giorgi, Antonio Russo, Edoardo Francini, the SPARTACUSS Investigators
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-7 (2023)
Abstract Background Metastatic castration-resistant prostate cancer remains a challenging condition to treat. Among the available therapeutic options, the androgen receptor signaling inhibitors abiraterone acetate plus prednisone (AA) and enzalutamid
Externí odkaz:
https://doaj.org/article/84102b9cf7624853a66205f87884b99c
Autor:
Sara Elena Rebuzzi, Alessio Signori, Giuseppe Luigi Banna, Annalice Gandini, Giuseppe Fornarini, Alessandra Damassi, Marco Maruzzo, Ugo De Giorgi, Umberto Basso, Silvia Chiellino, Luca Galli, Paolo Andrea Zucali, Emanuela Fantinel, Emanuele Naglieri, Giuseppe Procopio, Michele Milella, Francesco Boccardo, Lucia Fratino, Stefania Pipitone, Riccardo Ricotta, Stefano Panni, Veronica Mollica, Mariella Sorarù, Matteo Santoni, Alessio Cortellini, Veronica Prati, Hector Josè Soto Parra, Daniele Santini, Francesco Atzori, Marilena Di Napoli, Orazio Caffo, Marco Messina, Franco Morelli, Giuseppe Prati, Franco Nolè, Francesca Vignani, Alessia Cavo, Giandomenico Roviello, Pasquale Rescigno, Sebastiano Buti
Publikováno v:
Journal of Translational Medicine, Vol 20, Iss 1, Pp 1-7 (2022)
Abstract Background Nephrectomy is considered the backbone of managing patients with localized and selected metastatic renal cell carcinoma (mRCC). The prognostic role of nephrectomy has been widely investigated with cytokines and targeted therapy, b
Externí odkaz:
https://doaj.org/article/5d27a41c30724b90858c7fbb9dde10ad
Autor:
Marzia Del Re, Stefania Crucitta, Federico Paolieri, Federico Cucchiara, Elena Verzoni, Francesco Bloise, Raffaele Ciampi, Chiara Mercinelli, Annalisa Capuano, Liberata Sportiello, Antonia Martinetti, Giuseppe Procopio, Luca Galli, Camillo Porta, Sergio Bracarda, Romano Danesi
Publikováno v:
Journal of Translational Medicine, Vol 20, Iss 1, Pp 1-9 (2022)
Abstract Background Despite the increasing number of treatment options, reliable prognostic/predictive biomarkers are still missing for patients affected by metastatic clear cell renal cell carcinoma (mccRCC). Methods Patients with mccRCC undergoing
Externí odkaz:
https://doaj.org/article/fef037278a2f4851b867577c0a56cf60
Autor:
Giandomenico Roviello, Elisabetta Gambale, Roberta Giorgione, Daniele Santini, Marco Stellato, Giuseppe Fornarini, Sara Elena Rebuzzi, Umberto Basso, Davide Bimbatti, Laura Doni, Gabriella Nesi, Melissa Bersanelli, Sebastiano Buti, Ugo De Giorgi, Luca Galli, Andrea Sbrana, Raffaele Conca, Claudia Carella, Emanuele Naglieri, Sandro Pignata, Giuseppe Procopio, Lorenzo Antonuzzo
Publikováno v:
Cancer Medicine, Vol 11, Iss 16, Pp 3084-3092 (2022)
Abstract Background Nivolumab and cabozantinib are currently approved agents in metastatic renal cell carcinoma (mRCC) but there are no data available for patients progressing to both treatments. The aim of this study was to compare active therapeuti
Externí odkaz:
https://doaj.org/article/5c1b0d246d484bad81a6a45b350d5ccd